Tokyo, Japan

Mitsuru Naito

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Mitsuru Naito

Introduction

Mitsuru Naito is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of drug delivery systems, holding three patents that showcase his innovative approach to pharmaceutical compositions.

Latest Patents

One of his latest patents is focused on a temperature-responsive drug/polymer compound and its application in drug delivery. This drug-polymer conjugate features thermoresponsiveness, which allows it to form micellular aggregates in an aqueous medium at temperatures equal to or above the lower critical solution temperature. This innovative approach enables the drug-polymer conjugate to be administered and absorbed in the lungs effectively. Another notable patent is a pharmaceutical composition that includes polymer units α and β, each with a hydrophilic polymer chain bound to a cationic polymer chain. The arrangement of these polymer units forms a micelle that encapsulates the drug, enhancing its delivery and efficacy.

Career Highlights

Mitsuru Naito has worked at prestigious institutions such as the University of Tokyo and Tokyo Medical and Dental University. His research has focused on developing advanced drug delivery systems that improve therapeutic outcomes.

Collaborations

He has collaborated with notable colleagues, including Kazunori Kataoka and Takehiko Ishii, contributing to the advancement of innovative drug delivery technologies.

Conclusion

Mitsuru Naito's work in the field of drug delivery systems exemplifies the intersection of innovation and practical application in pharmaceuticals. His patents reflect a commitment to improving healthcare through advanced technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…